Patents by Inventor Cong-dat PHAM

Cong-dat PHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260317286
    Abstract: Small molecule inhibitors of the glutamine transporter ASCT2 and methods for their use are provided herein. The ASCT2 inhibitors described herein are useful in treating and/or preventing conditions or diseases associated with ASCT2-mediated glutamine transport, including cancer. Also provided are methods of inhibiting ASCT2-mediated glutamine transport in a cell using the inhibitors described herein.
    Type: Application
    Filed: June 29, 2023
    Publication date: October 15, 2026
    Inventors: Henry Charles MANNING, Cong-Dat PHAM, Allison S. COHEN, Jianbo WANG, Xiaoxia WEN, Robert TA
  • Patent number: 12679855
    Abstract: Provided herein are compounds of the formula: wherein the variables are defined herein. The present disclosure also provides pharmaceutical compositions comprising the compounds disclosed herein as well as methods of treatment using the compounds and/or compositions disclosed herein. Such compounds and compositions may be used, for example, for the inhibition of enolase enzymes.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: July 14, 2026
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Florian Muller, Victoria Yan, Kristine Yang, Elliot Ballato, Cong-dat Pham
  • Publication number: 20230167142
    Abstract: Provided is a method for the preparation of mono-amidated phosphates or phosphonates as well as mono-amidated phosphates and phosphonates prepared by such method.
    Type: Application
    Filed: September 30, 2022
    Publication date: June 1, 2023
    Inventors: Victoria YAN, Cong-Dat PHAM, Florian MULLER
  • Publication number: 20220089620
    Abstract: Provided herein are compounds of the formula: wherein the variables are defined herein. The present disclosure also provides pharmaceutical compositions comprising the compounds disclosed herein as well as methods of treatment using the compounds and/or compositions disclosed herein. Such compounds and compositions may be used, for example, for the inhibition of enolase enzymes.
    Type: Application
    Filed: January 27, 2020
    Publication date: March 24, 2022
    Applicant: Board of Regents, The University of Texas System
    Inventors: Florian MULLER, Victoria YAN, Kristine YANG, Elliot BALLATO, Cong-dat PHAM